Literature DB >> 27436813

Neutralizing antichlamydial activity of complement by chlamydia-secreted protease CPAF.

Zhangsheng Yang1, Lingli Tang2, Zhiguang Zhou3, Guangming Zhong4.   

Abstract

Ascending infection by sexually transmitted Chlamydia trachomatis is required for chlamydial induction of tubal pathology. To achieve ascension, the C. trachomatis organisms may have to spread from cell to cell, which inevitably exposes the organisms to extracellular mucosal effectors such as complement factors that are known to possess strong antichlamydial activities. Here, we report that the chlamydia-secreted protease CPAF efficiently neutralized complement factor C3-dependent antichlamydial activity. The neutralization was dependent on the proteolytic activity of CPAF and correlated with the CPAF-mediated degradation of complement factor C3 and factor B. As a result, CPAF preferentially inhibited the alternative complement activation pathway. The significance and limitation of these observations were discussed.
Copyright © 2016 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CPAF; Neutralization of antichlamydial activity; Proteolysis of complement factor C3 & factor B

Mesh:

Substances:

Year:  2016        PMID: 27436813     DOI: 10.1016/j.micinf.2016.07.002

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  9 in total

Review 1.  Chlamydia Spreading from the Genital Tract to the Gastrointestinal Tract - A Two-Hit Hypothesis.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2017-12-27       Impact factor: 17.079

2.  Chlamydia muridarum Induces Pathology in the Female Upper Genital Tract via Distinct Mechanisms.

Authors:  Heze Yu; Hui Lin; Lingxiang Xie; Lingli Tang; Jianlin Chen; Zhiguang Zhou; Jiangdong Ni; Guangming Zhong
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

Review 3.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

4.  Sulforaphane promotes chlamydial infection by suppressing mitochondrial protein oxidation and activation of complement C3.

Authors:  Daniel Saez; Rosine Dushime; Hanzhi Wu; Lourdes B Ramos Cordova; Kirtikar Shukla; Heather Brown-Harding; Cristina M Furdui; Allen W Tsang
Journal:  Protein Sci       Date:  2019-01       Impact factor: 6.725

5.  Detection of Chlamydia Developmental Forms and Secreted Effectors by Expansion Microscopy.

Authors:  Tobias C Kunz; Ralph Götz; Markus Sauer; Thomas Rudel
Journal:  Front Cell Infect Microbiol       Date:  2019-08-09       Impact factor: 5.293

6.  A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.

Authors:  Anja Weinreich Olsen; Ida Rosenkrands; Martin J Holland; Peter Andersen; Frank Follmann
Journal:  NPJ Vaccines       Date:  2021-04-19       Impact factor: 9.399

7.  A Novel Cleavage Pattern of Complement C5 Induced by Chlamydia trachomatis Infection via the Chlamydial Protease CPAF.

Authors:  Liang Peng; Jingping Gao; Zihao Hu; Hongbo Zhang; Lingli Tang; Fuyan Wang; Lei Cui; Shanshan Liu; Yujie Zhao; Hong Xu; Xin Su; Xiaojing Feng; Yiyuan Fang; Jianlin Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-11       Impact factor: 5.293

8.  Chlamydial Protease-Like Activity Factor and Type III Secreted Effectors Cooperate in Inhibition of p65 Nuclear Translocation.

Authors:  Michael John Patton; Stuart McCorrister; Chris Grant; Garrett Westmacott; Robert Fariss; Pingzhao Hu; Kaiqiong Zhao; Mary Blake; Bill Whitmire; Chunfu Yang; Harlan D Caldwell; Grant McClarty
Journal:  mBio       Date:  2016-09-27       Impact factor: 7.867

Review 9.  An Ancient Molecular Arms Race: Chlamydia vs. Membrane Attack Complex/Perforin (MACPF) Domain Proteins.

Authors:  Gabrielle Keb; Kenneth A Fields
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.